Wall St Engine(@wallstengine):$OABI SIGNS LILLY DEAL WORTH UP TO $370M OmniAb entered a global collaboration and licensing agreement with Eli Lilly for a new ion channel drug discovery program. OmniAb will receive an upfront payment and is eligible for up to $370M in research, development and commercial milestones, plus tiered royalties on global net sales. The target and therapeutic modality were not disclosed.

Wall St Engine

@wallstengine

Fast, accurate, consistent stock market news, earnings highlights & more. By Brillinsight. Not financial advice.

Joined March 2022

971 Following 195.9K Followers

Wall St Engine@wallstengine

2026.08.17 10:05

$OABI SIGNS LILLY DEAL WORTH UP TO $370M OmniAb entered a global collaboration and licensing agreement with Eli Lilly for a new ion channel drug discovery program. OmniAb will receive an upfront payment and is eligible for up to $370M in research, development and commercial milestones, plus tiered royalties on global net sales. The target and therapeutic modality were not disclosed.